RESUMEN
INTRODUCTION: This retrospective, cross-sectional, multi-center study aimed to evaluate the impact of laboratory results and treatments on the treatment response in patients diagnosed with tularemia. METHODS: The study included 190 adult patients diagnosed with tularemia between November 2023 and June 2024. RESULTS: 67.9% were female, mean age was 45.8±14.9 years. The most frequently detected symptoms were sore throat (74.2%), fatigue (71.6%), and neck swelling (56.3%). The most common form of tularemia was oropharyngeal (82.6%) and glandular (14.2%). The most used monotherapy was ciprofloxacin (80.5%, n=136), and combination therapy was streptomycin-ciprofloxacin (81.0%, n=17). Treatment failure was observed in 29 patients (15.2%). No difference was found between patients who responded and didn't respond to treatment regarding laboratory parameters. Lymph node drainage or excision was performed in 47 patients (23%). Suppurative lymphadenitis, abscess, necrosis, and conglomerate lymphadenopathy were more common in the lymph node drainage group. Reactive lymph nodes were more common in the group without lymph node drainage. There was no difference between the two groups regarding laboratory parameters of patients with and without lymph node drainage. The duration of antibiotic treatment was longer in patients who underwent lymph node drainage than in those who didn't. CONCLUSION: Radiological evaluation of lymph nodes upon hospital admission, in addition to antibiotic therapy during treatment, may help predict which patients are more likely to require surgical drainage. Laboratory parameters may not provide significant benefits in predicting the need for lymph node drainage and long-term treatment did not affect the treatment response.
